D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
MLTX holding history
MoonLake Immunotherapeutics in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MLTX overviewAll 13F holders of MLTXFull Q2 2026 holdings
- Shares (Q2 2026)
- 3,365,507
- Value
- $65.5M
- % of portfolio
- <0.1%
- Quarters held
- 8
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 3,365,507 | $65.5M | <0.1% | +974,846+40.8% | Added | Holders |
| Q1 2026 | 2,390,661 | $44.6M | <0.1% | −90,106−3.6% | Reduced | Holders |
| Q4 2025 | 2,480,767 | $32.7M | <0.1% | +2,480,767 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −128,700−100.0% | Sold out | Holders |
| Q4 2023 | 128,700 | $7.77M | <0.1% | +128,700 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −337,021−100.0% | Sold out | Holders |
| Q1 2022 | 337,021 | $3.74M | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 337,021 | $3.33M | <0.1% | +296,968+741.4% | Added | Holders |
| Q3 2021 | 40,053 | $395.0K | <0.1% | +17,040+74.0% | Added | Holders |
| Q2 2021 | 23,013 | $238.0K | <0.1% | +23,013 | New | Holders |